Swedish Orphan Biovitrum AB (publ) financials
Swedish Orphan Biovitrum AB (publ)
Country: SE Reporting currency: SEK Latest annual report: 2024-12-31
LEI:
549300124Y3MQI87PT35 Financial statements
(SEK, as reported — unscaled; 102 line items across 2 annual periods)
| Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Cost of sales | SEK 5.79B | SEK 5.00B |
| Gross profit | SEK 20.24B | SEK 17.13B |
| Other income | SEK 14.0M | SEK 9.0M |
| Operating profit (EBIT) | SEK 5.63B | SEK 4.07B |
| Net finance income / (cost) | -SEK 1.22B | -SEK 1.11B |
| Finance costs | SEK 1.30B | SEK 1.16B |
| Profit before tax | SEK 4.41B | SEK 2.95B |
| Income tax expense | SEK 528.0M | SEK 546.0M |
| Profit for the year | SEK 3.88B | SEK 2.41B |
| — attributable to owners | SEK 3.88B | SEK 2.41B |
| — attributable to NCI | -SEK 6.0M | SEK 0 |
| Total comprehensive income | SEK 5.75B | SEK 1.69B |
| Cash flow statement | ||
| Net cash from operating activities | SEK 7.39B | SEK 4.47B |
| Net cash from investing activities | -SEK 3.09B | -SEK 21.90B |
| Purchase of PP&E (capex) | SEK 170.0M | SEK 873.0M |
| Purchase of intangibles | SEK 2.83B | SEK 4.07B |
| Net cash from financing activities | -SEK 4.00B | SEK 17.01B |
| Proceeds from borrowings | SEK 14.22B | SEK 35.88B |
| Repayments of borrowings | SEK 18.66B | SEK 24.63B |
| Lease liability payments | SEK 170.0M | SEK 162.0M |
| Net change in cash | SEK 296.0M | -SEK 422.0M |
| Balance sheet | ||
| Total assets | SEK 75.44B | SEK 74.03B |
| Non-current assets | SEK 62.28B | SEK 61.87B |
| Intangible assets & goodwill | SEK 58.97B | SEK 59.58B |
| Current assets | SEK 13.16B | SEK 12.16B |
| Inventories | SEK 4.16B | SEK 3.87B |
| Trade & other receivables | SEK 5.20B | SEK 5.17B |
| Cash & equivalents | SEK 1.14B | SEK 904.0M |
| Total equity | SEK 40.30B | SEK 33.87B |
| — attributable to owners | SEK 40.29B | SEK 33.87B |
| Non-controlling interests | SEK 9.0M | SEK 0 |
| Non-current liabilities | SEK 22.55B | SEK 21.07B |
| Long-term borrowings | SEK 12.41B | SEK 11.36B |
| Lease liabilities (non-current) | SEK 268.0M | SEK 168.0M |
| Current liabilities | SEK 12.60B | SEK 19.09B |
| Lease liabilities (current) | SEK 134.0M | SEK 148.0M |
| Deferred tax liabilities | SEK 6.70B | SEK 6.68B |
| Derived metrics | ||
| Free cash flow | SEK 7.22B | SEK 3.60B |
| Operating margin | 21.6% | 18.4% |
| Net margin | 14.9% | 10.9% |
| Return on equity | 9.6% | 7.1% |
| Cash conversion ratio | 1.90× | 1.86× |
| Capex coverage | 43.46× | 5.12× |
| Other reported items | ||
| Additional Paidin Capital | SEK 17.19B | SEK 16.55B |
| Adjustments For Decrease Increase In Inventories | -SEK 159.0M | SEK 286.0M |
| Adjustments For Decrease Increase In Trade and Other Receivables | -SEK 178.0M | -SEK 900.0M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | SEK 3.68B | SEK 3.20B |
| Adjustments For Increase Decrease In Trade and Other Payables | SEK 157.0M | -SEK 546.0M |
| Adjustments For Interest Expense | SEK 1.11B | SEK 1.07B |
| Adjustments For Sharebased Payments | SEK 218.0M | SEK 194.0M |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -SEK 219.0M | -SEK 252.0M |
| Amount Removed From Reserve of Cash Flow Hedges and Included In Initial Cost Or Other Carrying Amount of Nonfinancial Asset Liability Or Firm Commitment For Which Fair Value Hedge Accounting Is Applied | — | SEK 712.0M |
| Cash Flows From Used In Operations Before Changes In Working Capital | SEK 7.57B | SEK 5.63B |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | SEK 0 | SEK 16.96B |
| Comprehensive Income Attributable To Noncontrolling Interests | -SEK 6.0M | SEK 0 |
| Comprehensive Income Attributable To Owners of Parent | SEK 5.76B | SEK 1.69B |
| Current Accruals and Current Deferred Income Including Current Contract Liabilities | SEK 5.67B | SEK 5.25B |
| Current Borrowings and Current Portion of Noncurrent Borrowings | SEK 3.93B | SEK 8.81B |
| Current Prepayments and Current Accrued Income Including Current Contract Assets | SEK 2.26B | SEK 1.61B |
| Current Provisions | SEK 531.0M | SEK 535.0M |
| Current Tax Liabilities Current | SEK 744.0M | SEK 74.0M |
| Decrease Increase Through Tax On Sharebased Payment Transactions | -SEK 30.0M | -SEK 26.0M |
| Deferred Tax Assets | SEK 1.29B | SEK 844.0M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -SEK 61.0M | -SEK 35.0M |
| Equity and Liabilities | SEK 75.44B | SEK 74.03B |
| Finance Income | SEK 86.0M | SEK 50.0M |
| Income Taxes Paid Refund Classified As Operating Activities | SEK 307.0M | SEK 641.0M |
| Increase Decrease Through Exercise of Options | SEK 2.0M | — |
| Increase Decrease Through Sharebased Payment Transactions | SEK 645.0M | SEK 375.0M |
| Increase Decrease Through Transactions With Owners | SEK 675.0M | SEK 6.36B |
| Increase Decrease Through Transfers and Other Changes Equity | SEK 0 | — |
| Interest Paid Classified As Operating Activities | SEK 1.09B | SEK 949.0M |
| Interest Received Classified As Operating Activities | SEK 34.0M | SEK 27.0M |
| Issued Capital Ordinary Shares | SEK 195.0M | SEK 194.0M |
| Noncurrent Financial Assets | SEK 166.0M | SEK 142.0M |
| Noncurrent Recognised Liabilities Defined Benefit Plan | SEK 276.0M | SEK 210.0M |
| Other Adjustments To Reconcile Profit Loss | -SEK 209.0M | SEK 76.0M |
| Other Comprehensive Income | SEK 1.87B | -SEK 719.0M |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | SEK 0 | SEK 645.0M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | SEK 2.14B | -SEK 1.35B |
| Other Comprehensive Income Net of Tax Gains Losses From Investments In Equity Instruments | -SEK 2.0M | -SEK 26.0M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | -SEK 81.0M | -SEK 69.0M |
| Other Comprehensive Income Net of Tax Hedges of Net Investments In Foreign Operations | -SEK 180.0M | SEK 78.0M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | SEK 1.96B | -SEK 624.0M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | -SEK 83.0M | -SEK 96.0M |
| Other Current Financial Liabilities | SEK 646.0M | SEK 3.25B |
| Other Current Receivables | SEK 405.0M | SEK 602.0M |
| Other Expense By Function | SEK 7.0M | SEK 115.0M |
| Other Noncurrent Assets | SEK 268.0M | SEK 0 |
| Other Noncurrent Financial Liabilities | SEK 2.84B | SEK 2.53B |
| Other Reserves | SEK 981.0M | -SEK 934.0M |
| Payments For Share Issue Costs | — | SEK 77.0M |
| Proceeds From Contributions of Noncontrolling Interests | SEK 15.0M | SEK 0 |
| Proceeds From Exercise of Options | SEK 427.0M | SEK 181.0M |
| Proceeds From Issuing Shares | — | SEK 6.02B |
| Purchase of Other Longterm Assets Classified As Investing Activities | SEK 85.0M | SEK 0 |
| Research and Development Expense | SEK 3.54B | SEK 2.80B |
| Retained Earnings Excluding Profit Loss For Reporting Period | SEK 18.04B | SEK 15.65B |
| Retained Earnings Profit Loss For Reporting Period | SEK 3.88B | SEK 2.41B |
| Revenue From Contracts With Customers | SEK 26.03B | SEK 22.12B |
| Selling General and Administrative Expense | SEK 11.09B | SEK 10.16B |
| Trade and Other Current Payables To Trade Suppliers | SEK 944.0M | SEK 1.02B |
Methodology
Every line item above is a fact tagged in Swedish Orphan Biovitrum AB (publ)'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (SEK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.